Keenova Publishes New Real-World Acthar Gel Autoimmune Data
DUBLIN, Ireland, July 13, 2026 Keenova Therapeutics plc has announced the publication of a new peer-reviewed real-world evidence study...
autoimmune diseases
Advertisement
GSK and Spero Secure FDA Nod for First Oral Carbapenem
LONDON, United Kingdom, June 18, 2026 GSK plc and Spero Therapeutics have achieved a major milestone in the fight...
Biogen Signs Landmark RayThera Acquisition Worth Up to $1 Billion
CAMBRIDGE, Mass. and SAN DIEGO, June 17, 2026 Biogen Inc. has announced a strategic agreement to acquire RayThera Inc....
LabGenius and LG Chem Partner on AI-Designed Cancer Antibodies
LONDON, United Kingdom, June 18, 2026 LabGenius Therapeutics and LG Chem have entered into a multi-year research collaboration, option,...
Samsung Bioepis and Organon Expand PYZCHIVA Rights in Canada
INCHEON, South Korea & KIRKLAND, Quebec, Canada, June 18, 2026 Samsung Bioepis and Organon have expanded their long-standing biosimilar...
Advertisements
Imviva Biotech Advances CTA313 CAR-T Program with FDA IND Approval
BOSTON, June 9, 2026 Imviva Biotech announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational...
argenx Reports Long-Term Efgartigimod Benefits in Myositis and Sjogren’s Disease at EULAR 2026
AMSTERDAM, Netherlands, June 3, 2026 argenx presented new clinical data at the European Alliance of Associations for Rheumatology (EULAR)...
Polpharma Biologics and Tuteur Sign LATAM Autoimmune Biosimilar Deal
WARSAW, Poland and BUENOS AIRES, Argentina, 22 May 2026 Polpharma Biologics has entered a major licensing agreement with Tuteur...
Sail Biomedicines Advances In Vivo eRNA CAR-T Data
CAMBRIDGE, Mass., April 27, 2026 Sail Biomedicines announced it will present new preclinical data supporting its In Vivo eRNA™...
Innovent Showcases Tri-Specific Autoimmune Therapy Data
SAN FRANCISCO & SUZHOU, China, April 9, 2026 Innovent Biologics, Inc. has unveiled preclinical data for its novel tri-specific...
Advertisement
